跳至主要内容
临床试验/NCT07321288
NCT07321288进行中(未招募)不适用

Identification of Risk Factors and Development of an Interpretable Machine Learning Model for Predicting Insulin Resistance in Patients With Psoriasis

Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 1,265 人开始时间: 2025年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,265
试验地点
1
主要终点
Insulin Resistance Status Assessed by the TyG Index

研究概览

简要总结

Psoriasis is a long-term inflammatory skin disease that can affect overall health. People with psoriasis have a higher risk of developing insulin resistance, a condition in which the body does not respond properly to insulin. Insulin resistance can increase the risk of diabetes, heart disease, and other serious health problems. Because insulin resistance often develops without clear symptoms, many patients are not diagnosed early.

The purpose of this study is to identify which patients with psoriasis are more likely to develop insulin resistance and to create a tool that can help doctors estimate this risk for individual patients. The study will use existing medical records from two medical centers. Researchers will analyze information such as age, body weight, psoriasis severity, blood test results, other medical conditions, and medication history.

Machine learning methods will be used to analyze these data and build a prediction model. The model will be designed to be easy to understand, so doctors can see which factors contribute most to insulin resistance risk.

This study does not involve any new treatments or procedures. All patient information will be anonymized to protect privacy. The results may help doctors identify high-risk patients earlier and support timely monitoring and preventive care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 years or older
  • Diagnosed with psoriasis (including plaque psoriasis, pustular psoriasis, erythrodermic psoriasis, or other clinically recognized subtypes), according to established clinical diagnostic guidelines
  • Received medical care at Chinese PLA General Hospital (First Medical Center) or the collaborating center (Fourth Medical Center) during the study period
  • Availability of complete medical records, including demographic information, relevant clinical characteristics, and laboratory data required to assess insulin resistance

排除标准

  • Previous or current diagnosis of diabetes mellitus
  • Presence of severe systemic diseases that may significantly affect glucose metabolism (such as malignant tumors, hyperthyroidism, or other serious endocrine disorders)
  • Current or recent use of systemic medications known to affect insulin sensitivity, including:Systemic corticosteroids,Glucose-lowering medications, or Other medications with known significant effects on insulin resistance
  • Pregnant or breastfeeding women
  • Medical records with missing key variables required for the assessment of insulin resistance or model development

结局指标

主要结局

Insulin Resistance Status Assessed by the TyG Index

时间窗: At baseline (using existing medical record data collected between January 2015 and June 2025)

Insulin resistance will be evaluated using the triglyceride-glucose (TyG) index, calculated from fasting triglyceride and fasting plasma glucose levels obtained from medical records. Participants will be classified as having insulin resistance or not based on a predefined TyG index cutoff value (TyG ≥ 8.5)

次要结局

未报告次要终点

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chongli Yu

Resident Physician

Chinese PLA General Hospital

研究点 (1)

Loading locations...

相似试验